47 results
8-K
EX-99.1
PCSA
Processa Pharmaceuticals Inc
28 Oct 13
Heatwurx Granted Additional Patent from the U.S. Patent and Trademark Office
12:00am
limitation, the success rate of business development efforts, industry and customer acceptance of its products, the ability to secure and protect its
8-K
EX-99.1
PCSA
Processa Pharmaceuticals Inc
21 Oct 13
Heatwurx Equipment Granted Patent from the U.S. Patent and Trademark Office
12:00am
development efforts, industry and customer acceptance of its products, the ability to secure and protect its intellectual property rights, and other
8-K
EX-99.1
PCSA
Processa Pharmaceuticals Inc
27 Nov 13
Heatwurx Names Dave Dworsky as Chief Executive officer
12:00am
, including, without limitation, the success rate of business development efforts, industry and customer acceptance of its products, the ability
424B3
PCSA
Processa Pharmaceuticals Inc
6 Jun 13
Prospectus supplement
12:00am
term as we do not have a large number of customer orders and do not have any urgent need for equipment. However, we anticipate that as our business … completion of design and development, implementation of manufacturing processes, and effective sales, marketing, and customer service. Because
8-K
EX-99.1
ut65zsb
9 Jul 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
3lv2tgjc
26 Sep 14
Regulation FD Disclosure
12:00am
10-K
6xbs57u 74pq
27 Mar 14
Annual report
12:00am
8-K
EX-99.1
zm7ul3
3 Nov 14
Separation and Severance Agreement
12:00am
8-K
EX-10.1
cqoe0p
13 Oct 20
Processa Pharmaceuticals Announces Appointment of Michael Floyd as Chief Operating Officer
9:30am
DEF 14A
mwaci8i
26 Apr 19
Definitive proxy
5:02pm
8-K
g8fby oun7o7k
12 Oct 17
Entry into a Material Definitive Agreement
12:00am